REFERENCES
- Marina N, Bielack S, Whelan J, International collaboration is feasible in trials for rare conditions: the EURAMOS experience. Cancer Treat Res. 2009;152:339–353.
- Hellier I, Bessis D, Sotto A, High-dose methotrexate-induced bullous variant of acral erythema. Arch Dermatol. 1996;132:590–591.
- Feizy V, Namazi MR, Barikbin B, Ehsani A. Methotrexate-induced acral erythema with bullous reaction. Dermatol Online J. 2003;9:14.
- Postovsky S, Ben Arush MW. Acral erythema caused by high-dose methotrexate therapy in patients with osteogenic sarcoma. Pediatr Hematol Oncol. 2005;22:167–173.
- Varela CR, McNamara J, Antaya RJ. Acral erythema with oral methotrexate in a child. Pediatr Dermatol. 2007;24:541–546.
- Werchniak AE, Chaffee S, Dinulos JG. Methotrexate-induced bullous acral erythema in a child. J Am Acad Dermatol. 2005;52:S93–S95.
- Tezer H, Kuskonmaz B, Kara A, et al. Intravenous immunoglobulin in the treatment of severe methotrexate-induced acral erythema. J Pediatr Hematol Oncol. 2008;30:391–393.
- Morrell DS, Challgren E, Eapen M, Esterly NB. Bullous acral erythema secondary to high-dose methotrexate. J Pediatr Hematol Oncol. 2002;24:240.